Zusammenfassung
Vaskulitiden sind entzündliche Erkrankungen der Blutgefäße, die in primäre und sekundäre Formen unterteilt werden. Sekundäre Vaskulitiden treten im Rahmen anderer Grunderkrankungen auf, z. B. bei Kollagenosen oder rheumatoider Arthritis. Auch können sekundäre Vaskulitiden durch Medikamente, Infektionen oder Neoplasien verursacht werden. In diesem Kapitel werden nur die primären Vaskulitiden besprochen. Eine Einteilung der Vaskulitiden erfolgt unter anderem basierend auf histologischen Veränderungen, anhand immunologischer Marker sowie des Gefäßkalibers. Die primären Vaskulitiden werden nach der Chapel-Hill-Klassifikation eingeteilt, die zuletzt 2012 revidiert wurde.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Akman-Demir G, Serdaroglu P, Tasçi B (1999) Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122:2171–2182
Alexander MD, Yuan C, Rutman A, Tirschwell DL, Palagallo G, Gandhi D, Sekhar LN, Mossa-Basha M (2016) High-resolution intracranial vessel wall imaging: imaging beyond the lumen. J Neurol Neurosurg Psychiatry 87(6):589–597
Alrawi A, Trobe JD, Blaivas M, Musch DC (1999) Brain biopsy in primary angiitis of the central nervous system. Neurology 53(4):858–860
Alreshaid AA, Powers WJ (2003) Prognosis of patients with suspected primary CNS angiitis and negative brain biopsy. Neurology 61(6):831–833
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134
Berlit P (2004) Cerebral vasculitis. Nervenarzt 75(8):817–828
Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. Arch Neurol 66:704–709
Bley TA, Reinhard M, Hauenstein C, Markl M, Warnatz K, Hetzel A, Uhl M, Vaith P, Langer M (2008) Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 58:2574–2578
Boyev LR, Miller NR, Green WR (1999) Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol 128:211–215
Calabrese LH (1997) Therapy of systemic vasculitis. Neurol Clin 15(4):973–991
Calabrese LH, Mallek JA (1997) Primary angiitis of the central nervous system. Report of 8 cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 76:20–39
Dasgupta B et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism/American college of rheumatology collaborative initiaitve. Ann Rheum Dis 71:484–492
Dejaco C et al (2015) 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 74:1799–1807
Demaerel P, De Ruyter N, Maes F, Velghe B, Wilms G (2004) Magnetic resonance angiography in suspected cerebral vasculitis. Eur Radiol 14(6):1005–1012
Ducros A (2012) Reversible cerebral vasoconstriktion syndrome. Lancet Neurol 11(10):906–917
Falk RJ, Hogan S, Carey TS, Jennette JC (1990) Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113:656–663
Gayraud M, Guillevin L, Toumelin P le, Cohen P, Lhote F, Casassus P, Jarrousse B, French Vasculitis Study Group (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44:666–675
Guillevin L, Lhote F, Sauvaget F et al (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53:334–337
Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28
Guillevin L, Lhote F, Gherardi R (1997) Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin 15:865–886
Hajj-Ali RA, Calabrese LH (2009) Central nervous system vasculitis. Curr Opin Rheumatol 21(1):10–18
Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E (2011) Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257–266
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122–1128
International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s Disease. Lancet 335:1078–1080
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11
Kidd D, Steuer A, Denman AM, Rudge P (1999) Neurological complications in Behçet’s syndrome. Brain 122:2183–2194
Kuker W (2007) Imaging of cerebral vasculitis. Int J Stroke 2(3):184–190
Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107
Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT et al (1990) The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093
Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY et al (1990) The American college of rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100
Miller DV, Salvarani C, Hunder GG, Brown RD, Parisi JE, Christianson TJ, Giannini C (2009) Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol 33:35–43
Néel A, Pagnoux C (2009) Primary angiitis of the central nervous system. Clin Exp Rheumatol 27(1 Suppl 52):S95–107
Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34:284–292
Petursdottir V, Johansson H, Nordborg E, Nordborg C (1999) The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations. Rheumatology 38:1208–12
Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99
Salvarani C, Brown RD Jr, Christianson T, Miller DV, Giannini C, Huston J 3rd, Hunder GG (2015) An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis. Description of 163 patients. Medicine 94(21):e738
Schmidt WA, Kraft HE, Vorpahl K, Völker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336–1342
Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A (2008) Prognosis of large-vessel giant cell arteritis. Rheumatology 47:1406–1408
Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L (2006) Central nervous system involvement in Wegener granulomatosis. Medicine 85:54–65
Siva A (2001) Vasculitis of the nervous system. J Neurol 248(6):451–468
Smeeth L, Cook C, Hall AJ (2006) Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001. Ann Rheum Dis 65:1093–1098
Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB (1994) Sensitivities of noninvasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography, and magnetic resonance imaging. J Rheumatol 21(7):1277–1282
Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221–232
Torres J, Loomis C, Cucchiara B, Smith M, Messé S (2016) Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis. Stroke 47(8):2127–2129
Vital A, Vital C (2006) Neuromuscular biopsy and diagnosis of vasculitis. Ann Pathol 26:247–255
Weyland CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371:50–57
Wipfler-Freissmuth E, Moosig F, Schirmer M (2009) Recommendations of the European League Against Rheumatism (EULAR) for the treatment of „large-vessel vasculitides“. Z Rheumatol 68:260–263
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Witte, T., Voß, E., Stangel, M. (2018). Neurologische Komplikationen der Vaskulitiden. In: Stangel, M., Mäurer, M. (eds) Autoimmunerkrankungen in der Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55530-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-55530-9_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55529-3
Online ISBN: 978-3-662-55530-9
eBook Packages: Medicine (German Language)